Author response for "Potential Unrealized Mortality Benefit of GLP-1 Receptor Agonists and SGLT2 Inhibitors: A Report from the Veterans Health Administration Clinical Assessment, Reporting, and Tracking (CART) Program"
Diabetes, Obesity and Metabolism(2020)
AI 理解论文
溯源树
样例

生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要